Abstract:Background: In recent years, preoperative nutrition has received great attention, especially for patients who received surgical reconstruction of the digestive tract such as esophagectomy. Preoperative nutrition therapy was reported to accelerate the patient's postoperative recovery. In addition, immune suppression, nausea, and vomiting may lead to poor immune and nutritional status of patients with esophageal cancer who underwent neoadjuvant chemotherapy (NAC), which is not conducive to surgery. Therefore, preoperative nutritional treatment is necessary for patients with esophageal cancer who underwent NAC. Method: Patients with esophageal cancer who received NAC at Nanjing Jinling Hospital from January 2018 to September 2020 were retrospectively identified. Patients were divided into enteral immunonutrition (EIN) group (those who received a conventional diet and immunonutrition supplement, Peptisorb, Nutricia, 500 mL/day * 7 via oral intake), and control group (those who only received a conventional diet were divided into). The primary outcomes were immune and nutritional indicators changes, including immunoglobulin M (IgM), immunoglobulin A (IgA), immunoglobulin G (IgG), and albumin (ALB), which were measured at preoperative day (PRD) 7, PRD-1, postoperative day (POD) 1 and POD-7. The secondary outcomes were postoperative complications, adverse reactions, and length of hospital stay. Results: A total of 124 eligible patients were included in the study, with 21 patients in EIN group. After 1:2 matching, significant difference in baseline characteristics between the two groups was not observed (EIN: n = 21, Control group: n = 42). Compared with the control group, the IgA is significantly increased in the EIN group at POD-7 (p = 0.017). However, we observed that the IgM level in the control group was significantly higher than those in the EIN group at POD-7 (p = 0.007). The incidence of pneumonia and total complications in the EIN group were significantly lower than those in control group (p = 0.024, p = 0.028, respectively). There is no significant difference in ALB and adverse reactions between two groups (p = 0.303, p = 0.108, respectively). Conclusion: Immunonutritional supplement after NAC is an effective strategy to improve the postoperative immune status of esophageal cancer patients and could reduce the incidence of infectious complication. More well-designed prospective studies are needed to verify and update our finding.

Effect of Postoperative Enteral Immunonutrition on the Nutritional and Immune Function in Patients with Gastric Carcinoma

Role of Enteral Immunonutrition in Patients with Gastric Carcinoma Undergoing Major Surgery

The effects of perioperative enteral immunonutrition in patients with gastric cancer

Effects of Perioperative Sequential Treatment on Recovery of Patients with Esophageal or Cardiac Carcinoma

The Effect of Postoperative Immune Enhanced Enteral Nutrition on Host Immune Function and Inflammatory Responses in Gastric Cancer Patients with Radical Gastrectomy

Preoperative Enteral Immunonutrition in Patients with Gastrointestinal Cancer

Influence of Early Postoperative Enteral Immunonutrition on Patients with Malignant Gastric Tumor

Effects of Neoadjuvant Chemotherapy with Parenteral Nutrition Support on Tumor Cell Proliferation in Gastric Carcinoma Patients

Postoperative Enteral Immunonutrition for Patients Undergoing Surgery for Gastric Cancer:A Meta Analysis

Effects of Early Enteral Immunonutrition on Postoperative Immune Function and Rehabilitation of Patients with Gastric Cancer and Nutritional Risk

Effect of Special Enteral Nutrition Support on Postoperative Immune Function of Patients with Gastric Cancer

Comparison of enteral immunonutrition and enteral nutrition in patients undergoing gastric cancer surgery: a systematic review and meta-analysis of randomized, controlled trials

The effect of combined preoperative chemotherapy and enteral immunonutrition on the prognosis of colorectal cancer

Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer

Effect of Postoperative Early Enteral Nutrition on Nutritional Status and Immune Function of the Patients with Gastrointestinal Carcinoma

Preoperative Enteral Immunonutrition Improves Postoperative Outcome in Patients with Gastrointestinal Cancer

Effect of enteral immunonutrition on postoperative outcomes in patients with gastrointestinal malignancy：a Meta-analysis

Effect of Enteral Immunonutrition on Immune, Inflammatory Markers and Nutritional Status in Gastric Cancer Patients Undergoing Gastrectomy: A Randomized Double-Blinded Controlled Trial

Effects of neoadjuvant chemotherapy combined with enteral nutrition on perioperative immunity, inflammation and intestinal flora in gastric cancer patients

Effect Observation of Nutritional Support on the Immune Function of Gastrointestinal Surgery Patients

Effect of two enteral immunonutrition formulas on immune function in Chinese patients with gastrointestinal cancers undergoing surgery: A secondary analysis of a randomized clinical trial.